Interní Med. 2017; 19(1): 16-18 | DOI: 10.36290/int.2017.046

New indications for mucolytics, Principles of cough treatment

MUDr. Stanislav Kos, CSc.
Český občanský spolek proti plicním nemocem (ČOPN)

Cough is the mechanism of airways defence. According to its duration it can be divided in adults in: acute with duration of up to

3 weeks, prolonged with intermittent duration from 3 do 8 weeks, chronic – lasting over 8 weeks.

According to its character cough may be divided in: dry, irritating cough that could develop in hoarse, husky voice – should be

treated with antitussives with central or peripheral effects, paroxysmal cough – predominantly during the night, or exercise induced,

may be the sign of astma. The relief could be reached by inhaled bronchodilators or antiinflammatives.

cough with sputum production is often connected with chronic bronchitis or COPD (= Chronic Obstructive Pulmonary Disease)

and should be treated with different types of mucolytic agents. These drugs should not be given simultaneously with antitussives

and at the same time they should have antiinflammatory effects and should potentiate the effects of antibiotics (erdostein, acetylcystein

and bromhexin or ambroxol could be mentioned). Nevertheless, any pacient with chronic cough should be carefully

examined by the specialist.

Keywords: cough – cough distinction according to its type and duration, principles of treatment with mucolytics

Received: January 20, 2018; Accepted: February 12, 2018; Published: February 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kos S. New indications for mucolytics, Principles of cough treatment. Interní Med. 2017;19(1):16-18. doi: 10.36290/int.2017.046.
Download citation

References

  1. Čáp P, Vondra V a kol. Akutní a chronický kašel. Mladá fronta, 2013: s. 159.
  2. Juřica J. Terapie kašle. Edukační materiál společnosti Angelini s. r. o., 2015.
  3. Koblížek V a kol. Doporučený postup ČPFS pro diagnostiku a léčbu chronické obstrukční plicní nemoci. Maxdorf, 2013: s. 134.
  4. Kopřiva F. Sledování ATB léčby dětských pacientů s recidivujícími respiračními infekcemi v letech 2013-2015 a Erdosteinu, aneb co nám řekla "ERICA". Vox Pediatriae - v tisku.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.